🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cancer Gi

Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers NCT02584244Phase 1, Phase 21 site📍 Boston Lumicell, Inc. · Tests: LUM015, LUM 2.6 Imaging Device Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom NCT03039309n/a1 site📍 Portsmouth Portsmouth Hospitals NHS Trust · Tests: Endoscopic Submucosal Dissection Development of Clinical and Biological Database NCT03449264NA1 site📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: biological collection MAESTRO Study: Metabolic Imaging to Improve Patient-Specific Therapy Outcomes NCT04534543NA2 sites📍 Amsterdam📍 Utrecht Academisch Medisch Centrum - Universiteit van Amsterdam (AM… · Tests: MRI/Spectroscopy Exploratory Clinical Evaluation of Personalized Functional Profiling in GI Tumors: Predicting Drug Response in CRC and PDAC NCT07500259n/a1 site📍 Luxembourg Luxembourg Institute of Health · Tests: Personalized Functional Profiling BGT007 Cells for the Treatment of Refractory Digestive System Tumors NCT06104241EARLY Phase 11 site📍 Xuzhou The Affiliated Hospital of Xuzhou Medical University · Tests: BGT007 Injection Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention NCT07649681NA6 sites📍 Augsburg📍 Erlangen📍 München Wuerzburg University Hospital · Tests: Gustabor server, Standard Recommendations EUS Guided HVA and PVA for Circulating Tumor DNA in Patients NCT04782557NA1 site📍 Hong Kong Chinese University of Hong Kong · Tests: EUS-guided portal vein and hepatic vein aspiration A First in Human Study of PLT012 in Participants With Solid Tumor Cancers NCT07337525Phase 14 sites📍 Los Angeles📍 Dallas📍 Houston Pilatus Biosciences Inc · Tests: PLT012 Feasibility Study of CBCT for IGRT in Cancer Patients NCT06681233NA4 sites📍 Columbus📍 Columbus📍 Columbus Varian, a Siemens Healthineers Company · Tests: Comparison of HyperSight CBCT imaging to conventional CBCT imaging. Dose Individualization of Chemotherapy in Patients With Gastrointestinal Cancers Lacking a Specific Liver Enzyme NCT06475352Phase 241 sites📍 Amiens📍 Aurillac📍 Avignon UNICANCER · Tests: FOLFOX regimen, CAPOX regimen Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies NCT06626269NA2 sites📍 Besançon📍 Dijon Centre Hospitalier Universitaire de Besancon · Tests: Blood sample, Tumor tissue Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer NCT04530890NA1 site📍 Poitiers Poitiers University Hospital · Tests: Blood samples Development of a Multi-biomarker Panel for Prognostic Stratification and Treatment Response Prediction in Acute Graft Versus Host Disease of the Gut NCT07305090n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna · Tests: Adult and pediatric patients with hematological diseases treated with allogeneic hematopoietic cell transplantation A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers NCT05789485Phase 28 sites📍 Hartford📍 Basking Ridge📍 Middletown Memorial Sloan Kettering Cancer Center · Tests: structured treadmill walking A Study of GC203 TIL in Advanced Malignant Solid Tumors NCT06375187Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Engineering Tumor Infiltrating Lymphocytes Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) NCT05482893Phase 1, Phase 211 sites📍 Duarte📍 Los Angeles📍 Denver Phanes Therapeutics · Tests: Spevatamig (PT886), Paclitaxel, Gemcitabine, Abraxane, KEYTRUDA® (pembrolizumab) PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis NCT06511037EARLY Phase 11 site📍 Orange University of California, Irvine · Tests: Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging Quality of Care in Relationship to Aborted Cancer Surgery NCT05808712n/a2 sites📍 Linköping📍 Linköping Linkoeping University · Tests: validation Ph II Intraperitoneal Paclitaxel + System Therapy in GI Ca w/Peritoneal Carcinomatosis (STOPGAP-B) NCT07795749Phase 21 site📍 Orange University of California, Irvine · Tests: Paclitaxel Q2W, Paclitaxcel Q3W Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer NCT02174549Phase 1, Phase 22 sites📍 Palo Alto📍 Philadelphia Teclison Ltd. · Tests: Tirapazamine, Conventional Transarterial Embolization (TAE) JUMP_START - Optimization of Care for Young Cancer Patients with Gastrointestinal Tumors NCT06621277n/a1 site📍 Heidelberg University Hospital Heidelberg · Tests: No intervention, Tailored counseling programs (Phase 2) ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive Cancers NCT05441163NA18 sites📍 Tours📍 Avignon📍 Bordeaux Institut Curie · Tests: APA and nutrition intervention Feasibility Effects of a Low-GI, High-fibre Diet in PCOS: a Prospective Cohort Study in Remote Yunnan NCT07426146n/a2 sites📍 Gengma County📍 Lincang Shanghai First Maternity and Infant Hospital · Tests: low glycemic index-high fiber BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion NCT07594626Phase 1, Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Pemetrexed, PRMT5 Inhibitor BMS-986504 A Real-World Study of Fecal Transplants for Cancer Therapy Side Effects NCT07319364Phase 11 site📍 Zhejiang Second Affiliated Hospital, Zhejiang University, School of … · Tests: Fecal microbiota transplantation (FMT) Resilience and Equity in Aging, Cancer, and Health (REACH) NCT04674267NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: Phase 2 Intervention - Geriatric Co-Management Electroacupuncture for Chemotherapy-Induced GI Symptom Clusters in Breast Cancer NCT06952920Phase 31 site📍 Xining Jiuda Zhao · Tests: electroacupuncture, standard quadruple antiemetic therapy, sham electroacupuncture, standard quadruple antiemetic thera… A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors NCT06500052Phase 11 site📍 Guangzhou Sichuan Baili Pharmaceutical Co., Ltd. · Tests: BL-M17D1 Breath Research Narrow Validation for Gastrointestinal Cancer Detection NCT07714538n/a6 sites📍 Maidstone📍 Liverpool📍 Glasgow Imperial College London
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy